TRAP-14 trifluoroacetate salt structure
|
Common Name | TRAP-14 trifluoroacetate salt | ||
---|---|---|---|---|
CAS Number | 137339-65-2 | Molecular Weight | 1739.92000 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C81H118N20O23 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | N/A |
Use of TRAP-14 trifluoroacetate saltSFLLRNPNDKYEPF is a synthetic thrombin receptor agonist peptide. |
Name | sfllrnpndkyepf |
---|---|
Synonym | More Synonyms |
Description | SFLLRNPNDKYEPF is a synthetic thrombin receptor agonist peptide. |
---|---|
Related Catalog | |
In Vitro | Thrombin cleaves its receptor at arginine-41, resulting in the generation of a new receptor NH2-terminus with the sequence SFLLRNPNDKYEPF. This peptide (TRP-14) may signal a variety of thrombin's responses[1]. SFLLRNPNDKYEPF, representing the 14 amino acids starting with Ser-42 of the human thrombin receptor, was found to mimic the effect of thrombin on platelets. Cleavage of the human platelet thrombin receptor by thrombin exposes a new N-terminal which acts as a putative tethered ligand. SFLLRNPNDKYEPF, corresponding to the new N-terminal region, activates and induces platelet aggregation and serotonin secretion. SFLLRNPNDKYEPF is the minimal peptide length which retains full activity in inducing [14C]serotonin secretion[2]. TRAP induces rapid morphological changes in HUVECs, with marked increase in the release of prostacyclin, endothelin, platelet activating factor, tissue type plasminogen activator, and plasminogen activator inhibitor-1. Incubation of cells with TRAP also induces a rapid decrease in cell-surface thrombomodulin[3]. |
References |
Molecular Formula | C81H118N20O23 |
---|---|
Molecular Weight | 1739.92000 |
Exact Mass | 1738.87000 |
PSA | 713.20000 |
LogP | 2.88170 |
Storage condition | −20°C |
Soluble expression and purification of receptor activator of nuclear factor-kappa B ligand using Escherichia coli.
J. Microbiol. Biotechnol. 25(2) , 274-9, (2015) Receptor activator of nuclear factor-kappa B ligand (RANKL) is a critical factor in osteoclastogenesis. It makes osteoclasts differentiate and multinucleate in bone remodeling. In the present study, R... |
|
The biocompatibility of degradable magnesium interference screws: an experimental study with sheep.
Biomed Res. Int. 2015 , 943603, (2015) Screws for ligament reconstruction are nowadays mostly made of poly-L-lactide (PLLA). However, magnesium-based biomaterials are gathering increased interest in this research field because of their goo... |
|
CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines.
Cancer Res. 74(23) , 7103-14, (2014) Src family kinases (SFK) integrate signal transduction for multiple receptors, regulating cellular proliferation, invasion, and metastasis in human cancer. Although Src is rarely mutated in human pros... |
MFCD00133815 |
Thrombin Receptor Activator |
Ser-phe-leu-leu-arg-asn-pro-asn-asp-lys-tyr-glu-pro-phe |
TRAP |
Thrombin Receptor Agonist Peptide |
Thrombin Receptor Activator Peptide |
Thrombin receptor agonist peptide-14 |
TRAP-14 |